Showing results (431-440 of 1,290) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|August 28, 2020
Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosisMitra Corral, Eunice Chang, Michael S Broder, et al.Journal of Comparative Effectiveness Research|April 8, 2020
Knowledge, awareness and perceptions of diabetes mellitus among the Saudi populationMuhammad H Mujammami, Abdulaziz A Alodhayani, Mohammad Ibrahim AlJabri, et al.Journal of Comparative Effectiveness Research|October 17, 2022
Cost standard set program: moving forward to standardization of cost assessment based on clinical conditionAna Paula Beck da Silva Etges, Richard D Urman, Anne Geubelle, et al.Journal of Comparative Effectiveness Research|July 18, 2025
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysisShannon Grabich, Brian Ung, Aalok Nadkar, et al.Journal of Comparative Effectiveness Research|June 17, 2025
Access in all areas? A round up of developments in market access and health technology assessment: part 8Sreeram V Ramagopalan, Annie Jullien PannelayJournal of Comparative Effectiveness Research|July 10, 2025
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedemaSarah Walsh, Anja Haltner, Meaghan Bartlett, et al.Journal of Comparative Effectiveness Research|July 8, 2025
Healthcare utilization and costs among patients with acromegaly in the United StatesTiffany P Quock, Eunice Chang, Ashis K Das, et al.Journal of Comparative Effectiveness Research|January 6, 2026
Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancerNeal Shore, Alicia K Morgans, Noman Paracha, et al.Journal of Comparative Effectiveness Research|December 15, 2025
Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary diseaseKrishnali Parsekar, Shubhram Pandey, Deniz Tansey-Dwyer, et al.Journal of Comparative Effectiveness Research|April 2, 2025
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance databaseGiovanna Tedesco Barcelos, Telma Peixoto, Jose Alvir, et al.Pageof 129